- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Prostalac Hip System for Infected Total Hip Arthroplasty
-
- Asaumi Koji
- Department of Orthopaedic Surgery Okayama Red Cross General Hospital
-
- Higashihara Shinhichiro
- Department of Orthopaedic Surgery Okayama Red Cross General Hospital
-
- Konishiike Taizo
- Department of Orthopaedic Surgery Okayama Red Cross General Hospital
-
- Umehara Norifumi
- Department of Orthopaedic Surgery Okayama Red Cross General Hospital
-
- Takada Eiichi
- Department of Orthopaedic Surgery Okayama Red Cross General Hospital
-
- Nasu Masayoshi
- Department of Orthopaedic Surgery Okayama Red Cross General Hospital
-
- Egawa Hiroshi
- Anderson Orthopaedic Research Institute Alexandria, VA, USA
-
- A. Engh, Sr. Charles
- Anderson Orthopaedic Research Institute Alexandria, VA, USA
Bibliographic Information
- Other Title
-
- 人工股関節置換術後感染に対する Prostalac Hip System の使用経験
Search this article
Description
Revision of infected total hip arthroplasty has had variable success and can be performed in single or double-stage procedures using antibiotics to treat the infections. From April to July 2006 we have treated a total of 5 patients suffering from infected total hip arthroplasty using the Prostalac hip system at Anderson Orthopaedic Research Institute. Several advantages are associated with the Prostalac hip system like, effective treatment of sepsis, reduction of patient morbidity and rehabilitation from prolonged immobility. Furthermore, it permits a less complicated approach to placement of the final arthroplasty components. The Prostalac hip is comprised of a cobalt chrome alloy core femoral component, a cobalt chrome alloy modular femoral head, a one-piece polyethylene acetabular component, a PMMA stem centering device and antibiotic-loaded bone cement. It has been designed to remain in situ for approximately three months after which a second surgery is performed for implantation of a permanent THA prosthesis. Considering the design characteristics of this device stress associated with full weight bearing should be avoided during the three month implantation period. We had the good results for all treated cases; unfortunately this system has not been approved in Japan.
Journal
-
- The Journal of the Chugoku-Shikoku Orthopaedic Association
-
The Journal of the Chugoku-Shikoku Orthopaedic Association 19 (1), 113-117, 2007
The Chugoku-Shikoku Orthopaedic Association
- Tweet
Details 詳細情報について
-
- CRID
- 1390282679324079872
-
- NII Article ID
- 130004438382
-
- ISSN
- 13475606
- 09152695
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- CiNii Articles
-
- Abstract License Flag
- Disallowed